eprintid: 17807 rev_number: 7 eprint_status: archive userid: 2 dir: disk0/00/01/78/07 datestamp: 2025-06-03 23:30:09 lastmod: 2025-06-03 23:30:09 status_changed: 2025-06-03 23:30:09 type: article metadata_visibility: show creators_name: Llobera, Natalia Daniela creators_name: Frias-Toral, Evelyn creators_name: Aquino, Mariel creators_name: Reberendo, María Jimena creators_name: Cardona Díaz, Laura creators_name: García, Adriana creators_name: Montalván, Martha creators_name: Velarde Sotres, Álvaro creators_name: Chapela, Sebastián creators_id: creators_id: creators_id: creators_id: creators_id: creators_id: creators_id: creators_id: alvaro.velarde@uneatlantico.es creators_id: title: Measurement of chest muscle mass in COVID-19 patients on mechanical ventilation using tomography ispublished: pub subjects: uneat_bm subjects: uneat_sn divisions: uneatlantico_produccion_cientifica divisions: uninimx_produccion_cientifica divisions: unic_produccion_cientifica full_text_status: none abstract: Background: Sarcopenia, characterized by a reduction in skeletal muscle mass and function, is a prevalent complication in the Intensive Care Unit (ICU) and is related to increased mortality. This study aims to determine whether muscle and fat mass measurements at the T12 and L1 vertebrae using chest tomography can predict mortality among critically ill COVID-19 patients requiring invasive mechanical ventilation (MV). Methods: Fifty-one critically ill COVID-19 patients on MV underwent chest tomography within 72 h of ICU admission. Muscle mass was measured using the Core Slicer program. Results: After adjustment for potential confounding factors related to background and clinical parameters, a 1-unit increase in muscle mass, subcutaneous, and intra-abdominal fat mass at the L1 level was associated with approximately 1–2% lower odds of negative outcomes and in-hospital mortality. No significant association was found between muscle mass at the T12 level and patient outcomes. Furthermore, no significant results were observed when considering a 1-standard deviation increase as the exposure variable. Conclusion: Measuring muscle mass using chest tomography at the T12 level does not effectively predict outcomes for ICU patients. However, muscle and fat mass at the L1 level may be associated with a lower risk of negative outcomes. Additional studies should explore other potential markers or methods to improve prognostic accuracy in this critically ill population. date: 2025-05 publication: Mediterranean Journal of Nutrition and Metabolism volume: 18 number: 2 pagerange: 87-94 id_number: doi:10.1177/1973798X251340155 refereed: TRUE issn: 1973-798X official_url: http://doi.org/10.1177/1973798X251340155 access: close language: en citation: Artículo Materias > Biomedicina Materias > Alimentación Universidad Europea del Atlántico > Investigación > Producción Científica Universidad Internacional Iberoamericana México > Investigación > Producción Científica Universidad Internacional do Cuanza > Investigación > Artículos y libros Cerrado Inglés Background: Sarcopenia, characterized by a reduction in skeletal muscle mass and function, is a prevalent complication in the Intensive Care Unit (ICU) and is related to increased mortality. This study aims to determine whether muscle and fat mass measurements at the T12 and L1 vertebrae using chest tomography can predict mortality among critically ill COVID-19 patients requiring invasive mechanical ventilation (MV). Methods: Fifty-one critically ill COVID-19 patients on MV underwent chest tomography within 72 h of ICU admission. Muscle mass was measured using the Core Slicer program. Results: After adjustment for potential confounding factors related to background and clinical parameters, a 1-unit increase in muscle mass, subcutaneous, and intra-abdominal fat mass at the L1 level was associated with approximately 1–2% lower odds of negative outcomes and in-hospital mortality. No significant association was found between muscle mass at the T12 level and patient outcomes. Furthermore, no significant results were observed when considering a 1-standard deviation increase as the exposure variable. Conclusion: Measuring muscle mass using chest tomography at the T12 level does not effectively predict outcomes for ICU patients. However, muscle and fat mass at the L1 level may be associated with a lower risk of negative outcomes. Additional studies should explore other potential markers or methods to improve prognostic accuracy in this critically ill population. metadata Llobera, Natalia Daniela; Frias-Toral, Evelyn; Aquino, Mariel; Reberendo, María Jimena; Cardona Díaz, Laura; García, Adriana; Montalván, Martha; Velarde Sotres, Álvaro y Chapela, Sebastián mail SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, SIN ESPECIFICAR, alvaro.velarde@uneatlantico.es, SIN ESPECIFICAR (2025) Measurement of chest muscle mass in COVID-19 patients on mechanical ventilation using tomography. Mediterranean Journal of Nutrition and Metabolism, 18 (2). pp. 87-94. ISSN 1973-798X